{
  "docId": "019de077-0285-7666-8a7c-e862967898bc",
  "docSlug": "fea13a4d561ba57c72ad56a940de546b",
  "documentTitle": "Evotec | Investor Presentation Deck | 49 slides",
  "authorId": "evotec",
  "authorName": "Evotec",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 27,
  "pageCount": 49,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "key_takeaways",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The chart shows a stacked area growth of various biologic modalities over time, highlighting the increasing share of complex biologics.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-0285-7666-8a7c-e862967898bc/27",
  "deckHref": "/decks/019de077-0285-7666-8a7c-e862967898bc",
  "deckJsonHref": "/decks/019de077-0285-7666-8a7c-e862967898bc.json",
  "deckAnchorHref": "/decks/019de077-0285-7666-8a7c-e862967898bc#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.3,
        "y": 0.47
      },
      "kind": "callout",
      "text": "Share of complex / unstable biologics rapidly growing",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d573dfb-1665-455d-ab4b-d18df8750fcf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.65,
        "x": 0.03,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Size of global pipeline by therapeutic modality",
      "attrs": null,
      "subkind": "area-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "53f798d0-795a-4e7b-a550-9ff2762cef47",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.1,
        "x": 0.85,
        "y": 0.7
      },
      "kind": "metric",
      "text": "~30%",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b1ee1fc-6e65-4bf7-b544-e18dc94a3e2d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.1,
        "x": 0.85,
        "y": 0.4
      },
      "kind": "metric",
      "text": ">40%",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "814d6322-689e-43ea-8766-d5a6686ed47b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.185,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "1 Innovative drugs only, excluding reformulations, biosimilars, diagnostics & imaging; snapshot as of June each year with missing phases not approximated; development status based on most progressed indication Source: Pharmaprojects Oct 2021; McKinsey analysis; interpolated data",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6fc56265-391c-4b7b-bd2d-11c66f6b7b07",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.185,
        "y": 0.04
      },
      "kind": "title",
      "text": "Our continuous platform will even further excel with complex biologics",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "57147ed8-7bd5-4fbe-b7ad-9c7098c439eb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.185,
        "y": 0.09
      },
      "kind": "title",
      "text": "Trends in global biologics pipelines",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a81d76a0-ff4b-4443-ac5d-27a7d8e67720",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Data Story Arc",
      "slug": "data-story-arc",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "ac5552aa-6940-44c4-91e8-8594312e3917",
      "evidence": "The slide presents trends in global biologics pipelines, which could imply a data story arc.",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 49,
      "from": 17,
      "beatId": "f8e500c2-a0e1-44fd-9184-3e9083983bf3",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "Call to action for investors and next steps",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 28,
      "from": 17,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "443f578a-8001-4541-ab44-14a6fb00a964",
      "evidence": "Highlighting success stories and market potential",
      "position": 1,
      "objective": "Presenting Evotec's growth potential",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}